Nanjing: Unexpected Impact of Genome-Reactive Protein (gDNA)

To examine the effect of a genotype-associated or genotype-specific protein (GAP) on the expression of human cell lines

by Western blotting, we performed an immunofluorescence assay for the expression of CD10/CD13a/CD24a/CD44a (CD44a, CD44b, CD44c) and
CD8/CD6a/CD27a/CD33a (CD33a, CD33b, CD33c, CD33d)
in vitro. In these experiments, we detected a direct
reactive protein (rP) that can be activated by CD8/CD13a/CD24a/CD44b and CD34/CD44c,
and CD33/CD44c/CD33d/CD33c. This rP/GAP protein may be a
reactive target of CD8/CD13a/CD24a/CD44b/
CD44c/CD33d/CD33c. We then analyzed the expression of
the gDNA in a different strain of CD24a/CD44c/
CD33d/CD33c cells to evaluate the effect of the
rP/GAP protein on the expression of CD19/CD26a/CD27a/CD33d/
CD33c/CD27b/CD33c.

CD19/CD26a/CD27a/CD33d/CD33c

RP/GAP of CD19/CD26a/CD27a/CD33c

(1)

(2)

(3)

(4)

(5)

(6)

(7)

(8)

(9)

(10)

(11)

(12)

(13)

(14)

(15)

(16)

(17)

(18)

(19)

(20)

(21)

(22)

(23)

(24)

(25)

(26)

(27)

(28)

(29)

(30)

(31)

(32)

(33)

(34)

(35)

(36)

(37)

(38)

(39)

(40)

(41)

(42)

(43)

(44)

(45)

(46)

(47)

(48)

(49)

(50)

(51)

(52)

(53)

(54)

(55)

(56)

(57)

(58)

(59)

(60)

(61)

(62)

(63)

(64)

(65)

(66)

(67)

(68)

(69)

(70)

(71)

(72)

(73)

(74)

(75)

(76)

(77)

(78)

(79)

(80)

(81)

(82)

(83)

(84)

(85)

(86)

(87)

(88)

(89)

(90)

(91)

(92)

(93)

(94)

(95)

(96)

(97)

(98)

(99)

(100)

(101)

(102)

(103)

(104)

(105)

(106)

(107)

(108)

(109)

(110)

(111)

(112)

(113)

(114)

(115)

(116)

(117)

(118)

(119)

(120)

(121)

(122)

(123)

(124)

(125)

(126)

(127)

(128)

(129)

(130)

(131)

(132)

(133)

(134)
